We found that fibroblasts from several patients with MLIII, the less severe form of mucolipidosis associated with residual levels of GlcNAc-phosphotransferase activity, did not efficiently support EBOV growth, suggesting that even a partial reduction in GNPTAB activity might be sufficient to reduce infection. Here, GNPTAB is linked to infection.